The estimated Net Worth of Minnie Baylor Henry is at least $97.9 Thousand dollars as of 19 September 2022. Ms. Henry owns over 6 units of Apyx Medical stock worth over $20 and over the last 6 years she sold APYX stock worth over $517. In addition, she makes $97,368 as Independent Director at Apyx Medical.
Sign up
Ms. Henry APYX stock SEC Form 4 insiders trading
Minnie has made over 3 trades of the Apyx Medical stock since 2019, according to the Form 4 filled with the SEC. Most recently she sold 6 units of APYX stock worth $517 on 19 September 2022.
The largest trade she's ever made was exercising 2,992 units of Apyx Medical stock on 10 December 2020 worth over $3,770. On average, Minnie trades about 207 units every 35 days since 2018. As of 19 September 2022 she still owns at least 16 units of Apyx Medical stock.
You can see the complete history of Ms. Henry stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Minnie Baylor-Henry biography
Minnie Baylor-Henry serves as Independent Director of the Company. Ms. Baylor-Henry has over 25 years of regulatory affairs experience. She is the President of B-Henry & Associates, LLC, a consulting firm that she founded to provide regulatory strategic support to life sciences companies. Prior to starting her consulting company, she held various executive level positions over a 15-year period at Johnson & Johnson (J&J). Before retiring from J&J in 2015, she was the Worldwide Vice President of Regulatory Affairs-Medical Devices. During her time at J&J, she also had served as the Vice President-Medical & Regulatory Affairs in the Over-the Counter Group, as well as Senior Director, Regulatory Affairs- Pharmaceuticals. Ms. Baylor-Henry also worked for Deloitte & Touche (2008-2010) as the National Director Regulatory Affairs- Life Sciences. Prior to joining the private sector, she worked for the US Food & Drug Administration (1991-1999) in many roles, including serving as the Director of the Division of Drug, Marketing, Advertising & Communications and the FDA’s National Health Fraud Coordinator. In 2018, Ms. Baylor-Henry joined the Board of Directors of scPharmaceuticals, a publicly-held company focused on developing technologies that enable subcutaneous administration of therapies and in 2019 the Board of Directors of PolarityTE, a publicly- held regenerative medicine company. Ms. Baylor-Henry received her pharmacy degree from Howard University’s College of Pharmacy and a law degree from Catholic University’s Columbus School of Law. The Company believes Ms. Baylor-Henry is qualified to serve as Director and Regulatory and Compliance Committee Chair because of her extensive experience in global and regulatory management and compliance.
What is the salary of Minnie Henry?
As the Independent Director of Apyx Medical, the total compensation of Minnie Henry at Apyx Medical is $97,368. There are 13 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.
How old is Minnie Henry?
Minnie Henry is 72, she's been the Independent Director of Apyx Medical since 2019. There are 3 older and 9 younger executives at Apyx Medical. The oldest executive at Apyx Medical Corporation is Andrew Makrides, 78, who is the Independent Chairman of the Board.
What's Minnie Henry's mailing address?
Minnie's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.
Insiders trading at Apyx Medical
Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin, and Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.
What does Apyx Medical do?
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
What does Apyx Medical's logo look like?
Complete history of Ms. Henry stock trades at Lantheus Inc, Paratek Pharmaceuticals, scPharmaceuticals Inc, PolarityTE Inc, and Apyx Medical
Apyx Medical executives and stock owners
Apyx Medical executives and other stock owners filed with the SEC include:
-
Charles Goodwin,
Chief Executive Officer, Director -
Todd Hornsby,
Executive Vice President -
Moshe Citronowicz,
Senior Vice President -
Tara Semb,
Chief Financial Officer, Treasurer, Secretary -
Charles D. Goodwin II,
Pres, CEO & Director -
Todd Hornsby,
Exec. VP -
Tara H. Semb,
CFO, Treasurer & Sec. -
Moshe Citronowicz,
Sr. VP -
Lawrence Waldman,
Lead Independent Director -
John Andres,
Independent Vice Chairman of the Board -
Andrew Makrides,
Independent Chairman of the Board -
Michael Geraghty,
Independent Director -
Craig Swandal,
Independent Director -
Minnie Baylor-Henry,
Independent Director -
Wendy Lauren Levine,
Director -
Matthew C Hill,
Chief Financial Officer -
Stavros G. Vizirgianakis,
Director